Status:
RECRUITING
EMVI as a Determinant of Metastasis in Colorectal Cancer
Lead Sponsor:
Imperial College London
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
16-100 years
Brief Summary
Bowel cancer is the fourth most commonly occurring cancer and the second highest cause of cancer deaths in the UK. Despite advances in treatment, over 40% of patients will die within 5 years. This is ...
Detailed Description
A retrospective ,non-interventional tissue study using archival materials collected through a patient's routine care, EVIDENCE aims to demonstrate that distant metastases in colorectal cancer are rela...
Eligibility Criteria
Inclusion Criteria:
- Are aged 16 years or over with colorectal cancer
- Colon / rectum has been surgically removed
- Distant metastases has been surgically removed
- Pre operative staging in the form of CT/MRI has been undertaken and images available for review
Exclusion Criteria:
- Pathological complete response in the primary tumour
- Local resection of the primary tumour
- Inadequate quantity of tissue sample to perform analyses
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06646341
Start Date
January 1 2023
End Date
December 31 2027
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hampshire Hospitals Nhs Foundation Trust
Basingstoke, Hampshire, United Kingdom, RG24 9NA